Monitoring, Progression, and Transplantation in ADTKD-SEC61A1

Managing a life with ADTKD-SEC61A1 is a long-term commitment to watchful monitoring. Because the disease is so rare, there is no validated, disease-specific schedule for SEC61A1. Instead, the medical team will create a personalized framework to track kidney health, blood counts, and overall growth over many years ^[1][2].

A Personalized Monitoring Plan

Routine follow-ups usually involve several types of checks:

• Kidney Function: Regular blood tests to measure creatinine and calculate the eGFR (estimated glomerular filtration rate) help track how well the kidneys are filtering waste ^[3]. Urinalysis will also check for protein or albumin levels.
• Blood Counts (CBC): Because this condition can cause anemia (low red blood cells) and neutropenia (low white blood cells), your doctor will perform periodic Complete Blood Counts with an Absolute Neutrophil Count (ANC) ^[1][4].
• Blood Pressure and Electrolytes: Monitoring for low blood pressure (hypotension) and salt imbalances is crucial, as some specific cases may need treatments like fludrocortisone to maintain balance ^[2]. Acid-base and mineral-bone markers are also routinely checked.
• Growth and Development: Since growth delays and neurological findings have been reported in some cases, your doctor will closely track height, weight, and developmental milestones ^[1][5].

The Trajectory of Kidney Decline

In ADTKD-SEC61A1, the progression to kidney failure—the point where the kidneys can no longer support the body—is highly variable.

While isolated case reports mention kidney failure occurring as early as age one, and others not until teenage years or early adulthood, these observations come from a tiny, ascertainment-biased case literature ^[2][1][5]. Because there are so few cases known worldwide, these reports do not define an expected, reliable age range for counseling an individual family ^[1]. The longitudinal eGFR trend over time is far more informative than comparing the journey to a handful of published cases.

Kidney Replacement and Transplantation

As kidney function declines, transplant evaluation may begin well before kidney failure is reached. Dialysis and preemptive transplantation are well-established options for managing advanced kidney disease.

If a kidney transplant is eventually required, the outlook is encouraging. While specific transplant data for the SEC61A1 subtype is essentially unavailable, general evidence from the broader ADTKD population shows that transplantation is considered a successful, long-term solution ^[6][7].

• Positive Survival: Patient and transplant (graft) survival outcomes in broader ADTKD cohorts are generally positive ^[6].
• No Kidney Recurrence: One of the most reassuring facts is that the genetic kidney disease does not return in the new kidney ^[6][7]. Because the donor kidney does not carry the SEC61A1 mutation, the “cellular doorway” (translocon) in the new kidney’s cells will function normally.
• Extra-Renal Persistence: It is crucial to understand that transplantation is not a complete cure for the systemic disease. It involves major surgery, lifelong immunosuppression, and risk of complications. Furthermore, transplantation replaces the kidney but does not correct the underlying SEC61A1 mutation in the rest of the body. Extra-renal manifestations, such as anemia, neutropenia, immune dysfunction, or growth issues, persist and require continued specialist care ^[4].
• Living Donor Safety: If a family member wishes to be a living donor, strict safeguards must be followed. The potential related donor must undergo targeted genetic testing for the known familial pathogenic variant ^[8]. A negative result does not guarantee donation, as they must still pass the transplant center’s full medical, blood-pressure, and cardiovascular evaluation. A relative who carries the pathogenic variant should generally not donate ^[9]. Donor suitability is ultimately decided by the transplant and genetics teams.

While the path involves frequent testing and many doctor visits, the ultimate goal of monitoring is to ensure that if a transplant is ever needed, the patient is in the best possible health to receive it.